Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Valve
2.3.2 Market Size By Material
2.3.3 Market Size By End Use
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1. Raw Material & Biomaterial Suppliers
3.4.2. Prosthetic Heart Valve Manufacturers & Component Providers
3.4.3. Distributors, Hospitals & Surgical Centers
3.4.4. Patients, Cardiac Surgeons & Healthcare Providers
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting (2025)
4.1 Prosthetic Heart Valve Procedure & Implantation Metrics
4.1.1 Global Heart Valve Replacement Procedure Volumes
4.1.2 Surgical vs. Transcatheter Valve Replacement Procedure Statistics
4.1.3 Average Prosthetic Valve Implantations per Cardiac Center
4.1.4 Valve Replacement Procedure Duration and Hospital Stay Benchmarks
4.2 Clinical Outcomes & Patient Safety Statistics
4.2.1 Prosthetic Valve Thrombosis and Thromboembolic Event Rates
4.2.2 Prosthetic Valve-Related Bleeding and Hemorrhage Statistics
4.2.3 Prosthetic Valve Endocarditis Incidence and Infection Rates
4.2.4 Reintervention, Readmission and Early Mortality Rates
4.3 Valve Performance & Durability Metrics
4.3.1 Prosthetic Valve Hemodynamic Performance Benchmarks
4.3.2 Structural Valve Deterioration and Failure Rates
4.3.3 Average Prosthetic Valve Durability and Longevity
4.3.4 Valve-in-Valve and Repeat Replacement Procedure Statistics
4.4 Clinical Adoption & Healthcare Utilization
4.4.1 Prosthetic Valve Adoption Across Cardiac Surgery Centers
4.4.2 Transcatheter Valve Therapy Utilization Trends
4.4.3 Multidisciplinary Heart Team Evaluation and Treatment Rates
4.4.4 Post-Implantation Echocardiography and Patient Monitoring Statistics
4.5 Procedure Economics & Resource Utilization
4.5.1 Average Prosthetic Valve Procedure Cost
4.5.2 Prosthetic Valve Device and Implantation Cost Benchmarks
4.5.3 Hospital Resource Utilization per Valve Replacement Procedure
4.5.4 Cost Impact of Readmissions and Prosthetic Valve Complications
4.6 Technology, Regulatory & Innovation Indicators
4.6.1 Next-Generation Prosthetic Valve Product Launch Activity
4.6.2 Clinical Trial and Regulatory Approval Activity
4.6.3 Prosthetic Valve Patent and Intellectual Property Trends
4.6.4 Minimally Invasive, Low-Profile and Durability-Focused Technology Development
5. Prosthetic Heart Valve Market Segmental Analysis & Forecast, By Valve, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Transcatheter Heart Valves
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 Bioprosthetic (Tissue) Valves
5.4 Mechanical Valves
6. Prosthetic Heart Valve Market Segmental Analysis & Forecast, By Material, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Biological Tissue
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Pyrolytic Carbon
6.4 Metal Alloys
6.5 Polymers
7. Prosthetic Heart Valve Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Hospitals
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Ambulatory Surgical Centers
7.4 Other End Users
8. Prosthetic Heart Valve Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 North America
8.2.1 Key Trends
8.2.2 Prosthetic Heart Valve Market Size & Forecast, By Valve, 2022–2035
8.2.3 Prosthetic Heart Valve Market Size & Forecast, By Material, 2022–2035
8.2.4 Prosthetic Heart Valve Market Size & Forecast, By End Use, 2022–2035
8.2.5 Prosthetic Heart Valve Market Size & Forecast, By Country, 2022–2035
8.2.5.1 USA
8.2.5.2 Canada
8.3 Europe
8.3.1 Key Trends
8.3.2 Prosthetic Heart Valve Market Size & Forecast, By Valve, 2022–2035
8.3.3 Prosthetic Heart Valve Market Size & Forecast, By Material, 2022–2035
8.3.4 Prosthetic Heart Valve Market Size & Forecast, By End Use, 2022–2035
8.3.5 Prosthetic Heart Valve Market Size & Forecast, By Country, 2022–2035
8.3.5.1 Germany
8.3.5.2 UK
8.3.5.3 France
8.3.5.4 Italy
8.3.5.5 Spain
8.3.5.6 Russia
8.3.5.7 Poland
8.3.5.8 Rest of Europe
8.4 Asia-Pacific
8.4.1 Key Trends
8.4.2 Prosthetic Heart Valve Market Size & Forecast, By Valve, 2022–2035
8.4.3 Prosthetic Heart Valve Market Size & Forecast, By Material, 2022–2035
8.4.4 Prosthetic Heart Valve Market Size & Forecast, By End Use, 2022–2035
8.4.5 Prosthetic Heart Valve Market Size & Forecast, By Country, 2022–2035
8.4.5.1 China
8.4.5.2 India
8.4.5.3 Japan
8.4.5.4 South Korea
8.4.5.5 Australia
8.4.5.6 ASEAN Countries
8.4.5.7 Rest of Asia-Pacific
8.5 Latin America
8.5.1 Key Trends
8.5.2 Prosthetic Heart Valve Market Size & Forecast, By Valve, 2022–2035
8.5.3 Prosthetic Heart Valve Market Size & Forecast, By Material, 2022–2035
8.5.4 Prosthetic Heart Valve Market Size & Forecast, By End Use, 2022–2035
8.5.5 Prosthetic Heart Valve Market Size & Forecast, By Country, 2022–2035
8.5.5.1 Brazil
8.5.5.2 Argentina
8.5.5.3 Mexico
8.5.5.4 Colombia
8.5.5.5 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Key Trends
8.6.2 Prosthetic Heart Valve Market Size & Forecast, By Valve, 2022–2035
8.6.3 Prosthetic Heart Valve Market Size & Forecast, By Material, 2022–2035
8.6.4 Prosthetic Heart Valve Market Size & Forecast, By End Use, 2022–2035
8.6.5 Prosthetic Heart Valve Market Size & Forecast, By Country, 2022–2035
8.6.5.1 UAE
8.6.5.2 Saudi Arabia
8.6.5.3 Qatar
8.6.5.4 South Africa
8.6.5.5 Rest of Middle East & Africa
9. Competitive Landscape
9.1 Key Players' Positioning
9.2 Competitive Developments
9.2.1 Year-Wise Strategies & Development, 2022–2026
9.3 Market Share Analysis, 2025
9.4 Product/Service & Application Benchmarking
9.4.1 Product/Service Specifications & Features By Key Players
9.4.2 Product/Service Heatmap By Key Players
9.4.3 Application Heatmap By Key Players
9.5 Industry Start-Up & Innovation Landscape
9.6 Key Company Profiles
9.6.1 Edwards Lifesciences Corporation
9.6.1.1 Company Overview & Snapshot
9.6.1.2 Product/Service Portfolio
9.6.1.3 Key Company Financials
9.6.1.4 Geographical Presence
9.6.1.5 SWOT Analysis
9.6.2 Medtronic plc
9.6.3 Abbott Laboratories
9.6.4 Boston Scientific Corporation
9.6.5 Artivion, Inc.
9.6.6 MicroPort Scientific Corporation
9.6.7 Lepu Medical Technology (Beijing) Co., Ltd.
9.6.8 Venus Medtech (Hangzhou) Inc.
9.6.9 Foldax, Inc.
9.6.10 Meril Life Sciences
9.6.11 TTK Healthcare Limited
9.6.12 LivaNova PLC
9.6.13 Corcym S.r.l.
9.6.14 4C Medical Technologies, Inc.
9.6.15 Colibri Heart Valve, LLC
9.6.16 Biotronik SE & Co. KG
9.6.17 B. Braun Melsungen AG
9.6.18 Sulzer AG
9.6.19 Cardiovalve Ltd.
9.6.20 JenaValve Technology, Inc.
10. Analyst Recommendations
10.1 SNS Insider Opportunity Map
10.2 Industry Low-Hanging Fruit Assessment
10.3 Market Entry & Growth Strategy
10.4 Analyst Viewpoint & Suggestions On Market Growth
11. Assumptions
12. Disclaimer
13. Appendix
13.1 List Of Tables
13.2 List Of Figures
Frequently Asked Questions
Key players include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Artivion Inc., MicroPort Scientific Corporation, Meril Life Sciences, and LivaNova PLC, among others.
Key opportunities include expanding transcatheter valve indications for mitral and tricuspid diseases, AI-assisted implantation systems, and manufacturer expansion across emerging Asia Pacific and Latin American markets.
The primary growth factor is the rising global prevalence of valvular heart disease among an expanding aging population, which is driving demand for both surgical and transcatheter valve replacement procedures.
By valve, the Transcatheter Heart Valves segment dominates the Prosthetic Heart Valve Market with approximately 47.50% share in 2025.
North America dominates the Prosthetic Heart Valve Market with approximately 45.00% share in 2025.